Comparative evaluation of the DPP (R) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis

Carregando...
Imagem de Miniatura
Citações na Scopus
60
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE BV
Autores
Citação
VETERINARY PARASITOLOGY, v.205, n.3-4, p.444-450, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We investigated the performance of the DPP (R) canine visceral leishmaniasis (CVL) rapid test, a novel immunochromatographic assay launched by BioManguinhos (Brazil), which was recently included in the new Brazilian protocol for screening CVL in serological surveys. The present study compared the DPP (R) with the ELISA and IFA produced by BioManguinhos (Brazil) both with L. major-like antigens and with in-house tests using Leishmania infantum chagasi (in-house ELISA and in-house IFA). We analyzed the sera from clinically symptomatic (n = 47) and asymptomatic (n = 38) infected dogs from an endemic area of CVL, as well as from healthy (n = 18) dogs, in addition to the sera of dogs (n = 81) infected with other pathogens. The DPP (R) and the in-house ELISA showed a sensitivity of 90.6% and 94.1%, respectively, and specificity of 95.1% and 97.5%, respectively, and both presented cross-reactivity only with the sera of dogs with babesiosis, 44% for the DPP (R) and 22% for the in-house ELISA. The clinical groups were detected equally by the two assays. The ELISA BioManguinhos, IFA BioManguinhos, and in house-IFA showed a good sensitivity, 90.6%, 96.5% and 89.4%, respectively, but very low specificity, 77.8%, 69.1% and 65.8%, respectively, due to the high cross-reactivity with the sera from the animals harboring other pathogens. The in-house ELISA provided the highest accuracy (95.8%), followed by the DPP (R) (92.7%), ELISA BioManguinhos (84.3%), IFA BioManguinhos (83.1%), and in-house IFA (78.0%). The simultaneous use of the DPP (R) and ELISA BioManguinhos reached a sensitivity of 99.1% and 82.1% when used sequentially. In conclusion, the DPP (R) performed well as serological test for CVL, and detected both asymptomatic and symptomatic dogs in equal proportions. Although its sensitivity is not ideal yet, discarding the IFA and including the DPP (R) improved the accuracy of the new Brazilian CVL diagnostic protocol, particularly of detecting truly infected dogs. Moreover, considering the higher specificity of DPP (R) (95.1% vs 77.8%), positive predictive value (95.1% vs 81.1%) and positive likelihood value (18.3% vs 4.1%) in comparison with the ELISA BioManguinhos, the use of DPP (R) as a confirmatory test instead of a screening test is suggested.
Palavras-chave
Canine leishmaniasis, Serological diagnosis, Enzyme-linked immunosorbent assay (ELISA), Indirect fluorescence test (IFA), DPP (R) CVL rapid test, Cross-reactivity
Referências
  1. Almeida MAO, 2005, VET PARASITOL, V127, P227, DOI 10.1016/j.vetpar.2004.10.010
  2. Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X
  3. Coura-Vital W., 2013, PLOS ONE, V9
  4. Da Costa RT, 2003, T ROY SOC TROP MED H, V97, P678
  5. da Silva DA, 2013, VET J, V195, P252, DOI 10.1016/j.tvjl.2012.06.010
  6. Dietze R, 1997, CLIN INFECT DIS, V25, P1240, DOI 10.1086/516096
  7. Ferreira SD, 2008, VET PARASITOL, V152, P257, DOI 10.1016/j.vetpar.2007.12.022
  8. Manzillo VF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002225
  9. Fraga D.B., 2014, PARASITE VECTOR, V7
  10. Grimaldi G, 2012, T ROY SOC TROP MED H, V106, P54, DOI 10.1016/j.trstmh.2011.10.001
  11. Lainson R., 1987, LEISHMANIASES BIOL M, V1, P1
  12. Laurenti MD, 2013, VET PARASITOL, V196, P296, DOI 10.1016/j.vetpar.2013.03.017
  13. Lemos EM, 2008, ACTA TROP, V107, P205, DOI 10.1016/j.actatropica.2008.04.023
  14. Lira RA, 2006, VET PARASITOL, V137, P11, DOI 10.1016/j.vetpar.2005.12.020
  15. MARZOCHI M C A, 1985, Memorias do Instituto Oswaldo Cruz, V80, P349
  16. Mettler M, 2005, J CLIN MICROBIOL, V43, P5515, DOI 10.1128/JCM.43.11.5515-5519.2005
  17. Moreira MAB, 2007, VET PARASITOL, V145, P245, DOI 10.1016/j.vetpar.2006.12.012
  18. Oliva G, 2006, J CLIN MICROBIOL, V44, P1318, DOI 10.1128/JCM.44.4.1318-1322.2006
  19. ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39
  20. Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06
  21. Quinnell RJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001992
  22. Rosário Eliza Yoshie do, 2005, Mem Inst Oswaldo Cruz, V100, P197
  23. Zanette MF, 2014, REV SOC BRAS MED TRO, V47, P105, DOI 10.1590/0037-8682-1723-2013